Skip to main content
OpenTrials
Completed

NCT Number: NCT01617265

Study of a Strategy to Prevent Oversedation in Intensive Care Patients Under Mechanical Ventilation

The purpose of the present study is to determine whether administration of sedation according to a strategy including a bundle of measures to prevent oversedation is associated with a reduction in mortality of intensive care unit patients requiring mechanical ventilation, compared to administration of sedation according to usual practices.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hôpital Saint-Esprit, Agen, France

Loading trial locations.

About this study

In intensive care unit (ICU) patients receiving mechanical ventilation (MV), potent hypnotics and morphinics are frequently administered to increase synchrony with the ventilator, control agitation and decrease discomfort and pain due to the tracheal tube, bed ridding, painful condition and diagnostic or therapeutic procedures.

However, administration sedatives or morphinics is often excessive and may result in deep and prolonged alteration of consciousness, delayed weaning from MV and prolonged MV. and exposes the patient to a higher risk of ventilator-associated pneumonia, ICU delirium and neuromuscular weakness at awakening.

The present randomized multicenter study will compare the day-90 mortality of a group of patients receiving conventional sedation to the mortality of a group of patients receiving sedation administered according to an algorithm aimed to prevent oversedation to the mortality. The algorithm is built on a graduate therapeutic response to increasingly intense symptoms of discomfort, pain, ventilator dyssynchrony and agitation, and includes the use of analgesics, non hypnotic benzodiazepines, neuroleptics, repeated intravenous (IV) boluses of hypnotics and short duration (6 hours) IV hypnotic infusions.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 and older
  • Admission to ICU with expected mechanical ventilation duration > 48 hrs
  • Mechanical ventilation in ICU for less than 12 hours
  • Information provided to the patient or proxy

Exclusion criteria

  • ICU Admission after cardiac arrest
  • Acute or chronic neuromuscular disease
  • Tracheotomy on ICU admission
  • Acute cerebral injury with intracranial hypertension requiring continuous IV sedation with or without neuromuscular blockade
  • Status epilepticus
  • Treatment withdrawal decision
  • Pregnancy, breast feeding
  • Concurrent participation in another interventional study requiring a change in usual practice of sedation or mechanical ventilation

Treatment and study plan

Clinical Procedure to Prevent Oversedation

Procedure

Sedation and analgesia will be administered according to a bundle of measures aimed at limiting oversedation, including repeated assessment of patients needs and graduate therapeutic response to control pain, discomfort, poor synchrony with the ventilator and agitation. The therapeutic options include non hypnotic anxiolytics, repeated IV hypnotics boluses, short-duration (6 hours) IV hypnotics infusion and round the clock IV hypnotics infusion.

Usual sedation practice

Procedure

Sedation and analgesia will be administered according to the usual practices in each participating center.

Primary outcomes

  1. Day-90 mortality

    Time frame: Mortality at Day 90 after randomization

Secondary outcomes

  1. Mortality at Day 28

    Time frame: at day 28

  2. Hospital mortality

    Time frame: at hospital discharge, up to day 90

  3. 1-yr mortality

    Time frame: at 1 yr

  4. Mechanical ventilation duration

    Time frame: From onset of mechanical ventilation to day 28

  5. Days alive with no mechanical ventilation

    Time frame: From ICU admission up to day 28

  6. Occurence of ventilator-associated pneumonia

    Time frame: During mechanical ventilation duration, up to day 28

  7. Use of non-invasive ventilation after extubation

    Time frame: From extubation to ICU discharge up to day 28

  8. Duration of ICU stay

    Time frame: From ICU admission to ICU discharge or death in ICU, up to day 90

  9. ICU confusion

    Time frame: From Day 1 to 7, and at day 14, 21 and 28

    Number of patients alive, awaken, and free of ICU-delirium assessed on the CAM-ICU

  10. Proximal muscle weakness

    Time frame: from day 1 to 7, and at day 14, 21 and 28

    Number of patients alive, awaken, cooperative and free of proximal muscle weakness

  11. Functional, cognitive and psychological status

    Time frame: At day 90 and 1 year

    Functional status (measured on the Barthel scale), depression (measured on the Hospital Anxiety & Depression Scale), Posttraumatic stress disorder (measured on the Impact of Event Scale), Quality of Life (measured on the SF-36) and patient living location

  12. Time to weaning onset

    Time frame: Time from mechancial ventilation initiation to first spontaneous breathing trial, up to day 28

  13. Number of patients requiring tracheotomy

    Time frame: During ICU stay, up to day 28

  14. First sitting in chair

    Time frame: During ICU stay, up to day 28

Sponsors and collaborators

Lead sponsor

French Society for Intensive Care

Other

Collaborators

  • University Hospital, Tours

Registry information

Official study title

Prevention of Oversedation in Intensive Care Patients Under Mechanical Ventilation : the AWARE Multicentric Randomized Trial

Acronym: AWARE

Important dates

Study start
2012
Primary completion
2015
Study completion
2015
First posted
Jun 12, 2012
Registry last updated
Aug 26, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.